Systematic Reviews of Treatments for the Prevention of Heart, Stroke and Vascular Disease

Follow the links below to find systematic reviews of evidence of the effectiveness of treatments in preventing heart, stroke and vascular diseases.

Reviewed January 2012

Printer friendly page Printer friendly page

8 Resources Found

Results 1 to 8 displayed.

Title:   Pain management for rheumatoid arthritis with cardiovascular or renal comorbidity
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This summary of a Cochrane review presents what we know from research about the safety of using pain-relieving drugs in people with rheumatoid arthritis who also have either heart or kidney disease, or both. What is rheumatoid arthritis and what is pai...
Date:   May 2010
Title:   Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Low-dose aspirin as antiplatelet therapy is still the drug of choice for preventing cardiovascular events, but the protection aspirin gives to people at high risk of cardiovascular events is only relatively modest. This review of 28,165 people in two tr...
Date:   Feb 2010
Title:   Treatments for depression in patients with coronary artery disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This review examined clinical trials on psychological treatments and antidepressant drugs in depressed patients with coronary artery disease. The objective was to determine the effects of these treatments on depression, death rates, cardiac events such ...
Date:   Jan 2010
Title:   B-complex vitamin therapy for preventing cardiovascular events
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cardiovascular disease is the number one cause of death worldwide. The most common causes of its morbidity and mortality are ischaemic heart disease, stroke and congestive heart failure. Many people with cardiovascular diseases may be asymptomatic, and...
Date:   Aug 2008
Title:   Statins cause a significant reduction in the risk of all-cause and cardiovascular mortality in CKD patients who are not requiring dialysis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with chronic kidney disease (CKD) are at very high risk of heart disease. Statins have been shown to decrease cholesterol levels and mortality in the general population. The aim of this review was to analyse if a similar effect could be shown...
Date:   Apr 2008
Title:   Antiplatelet drugs for preventing arterial and venous thrombotic events in patients with polycythaemia vera or essential thrombocythaemia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Low-dose aspirin as an antiplatelet therapy is the drug of choice for preventing cardiovascular events, but the potential risk of bleeding has limited its use in myeloproliferative disorders in the past. This review of 630 people in two trials found tha...
Date:   Jan 2008
Title:   HMG CoA reductase inhibitors (statins) for kidney transplant recipients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Kidney transplant recipients are at high risk of heart disease and dyslipidaemia further increases this risk. Statins have been shown to decrease cholesterol levels, cardiovascular events and mortality in the general population. The aim of this review w...
Date:   Nov 2007
Title:   Statins for the primary prevention of cardiovascular disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cardiovascular disease (CVD) is ranked as the number one cause of mortality and is a major cause of morbidity world wide. Reducing high blood cholesterol which is a risk factor for CVD events is an important goal of medical treatment. Statins are the fi...
Date:   Sep 2007

Results 1 to 8 displayed.